-
-
-
-
-
-
-
Form 4 Therapeutics Acquisition For: Jun 24 Filed by: Kolchinsky Peter
-
-
-
-
-
-
-
Form 425 Therapeutics Acquisition Filed by: Therapeutics Acquisition Corp.
-
-
-
-
-
-
-
POINT Biopharma Announces First Patients Dosed in Phase 3 Study of PNT2002 for mCRPC
-
-
-
-
-
-
-
Form SC 13G Therapeutics Acquisition Filed by: RIVERVIEW GROUP LLC
-
-
-
-
-
-
-
Form S-4 Therapeutics Acquisition
-
-
-
-
-
-
-
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
-
-
-
-
-
-
-
Form SC 13G Therapeutics Acquisition Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
1,182,407 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

